U.S. Markets closed
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • Dow 30

    29,590.41
    -486.27 (-1.62%)
     
  • Nasdaq

    10,867.93
    -198.88 (-1.80%)
     
  • Russell 2000

    1,679.59
    -42.72 (-2.48%)
     
  • Crude Oil

    79.43
    -4.06 (-4.86%)
     
  • Gold

    1,651.70
    -29.40 (-1.75%)
     
  • Silver

    18.83
    -0.78 (-3.99%)
     
  • EUR/USD

    0.9693
    -0.0145 (-1.4733%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • Vix

    29.92
    +2.57 (+9.40%)
     
  • GBP/USD

    1.0857
    -0.0398 (-3.5360%)
     
  • USD/JPY

    143.3300
    +0.9950 (+0.6991%)
     
  • BTC-USD

    19,060.52
    +37.69 (+0.20%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    27,153.83
    -159.30 (-0.58%)
     

Becton, Dickinson: Q1 Earnings Insights

·1 min read

 

Shares of Becton, Dickinson (NYSE:BDX) moved higher by 0.0% in pre-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share rose 71.70% over the past year to $4.55, which beat the estimate of $3.11.

Revenue of $5,315,000,000 higher by 25.80% from the same period last year, which beat the estimate of $4,880,000,000.

Guidance

The upcoming fiscal year's EPS expected to be between $12.75 and $12.85.

The upcoming fiscal year's revenue expected to be between $19,171,000,000 and $19,513,000,000.

Details Of The Call

Date: Feb 04, 2021

View more earnings on BDX

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/isdudxg2

Price Action

Company's 52-week high was at $286.72

Company's 52-week low was at $197.75

Price action over last quarter: Up 10.22%

Company Description

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.